Net profit of Vaishali Pharma declined 40.10% to Rs 1.18 crore in the quarter ended September 2025 as against Rs 1.97 crore during the previous quarter ended September 2024. Sales rose 60.89% to Rs 33.45 crore in the quarter ended September 2025 as against Rs 20.79 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales33.4520.79 61 OPM %4.1311.64 - PBDT1.822.75 -34 PBT1.652.63 -37 NP1.181.97 -40 Powered by Capital Market - Live News

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Vaishali Pharma announced that the 15th Annual General Meeting(AGM) of the company will be held on 22 September 2025.Powered by Capital Market - Live News

Net profit of Vaishali Pharma declined 24.71% to Rs 1.28 crore in the quarter ended June 2025 as against Rs 1.70 crore during the previous quarter ended June 2024. Sales rose 31.36% to Rs 23.75 crore in the quarter ended June 2025 as against Rs 18.08 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.7518.08 31 OPM %5.7713.00 - PBDT1.882.39 -21 PBT1.742.27 -23 NP1.281.70 -25 Powered by Capital Market - Live News

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 11 August 2025.Powered by Capital Market - Live News